MARKET RADAR
SENSEX     NIFTY      Refresh
YOU ARE HERE >  Moneycontrol >  Markets > Announcements >  Pharmaceuticals > Announcement - Sun Pharma
Sun Pharma
BSE: 524715NSE: SUNPHARMAISIN: INE044A01036

1st-Aug-2012 16:40Source: NSE

Sun Pharmaceuticals Industries Limited Disclosure under SEBI Takeover Regulations

Jayant S. Sanghvi has submitted to the Exchange vide letter dated July 30, 2012, a copy of Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

More Announcements on:

20th-May-2013 16:17Source: BSE

Sun Pharma - Board Meeting on May 28, 2013

17th-May-2013 15:38Source: NSE

Sun Pharmaceuticals Industries Limited

13th-May-2013 15:45Source: BSE

Sun Pharma - FY13 results on May 28, 2013

30th-Apr-2013 16:25Source: BSE

Sun Pharma - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

30th-Apr-2013 15:02Source: NSE

Sun Pharmaceuticals Industries Limited

16th-Apr-2013 12:20Source: BSE

Sun Pharma - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

15th-Apr-2013 11:42Source: BSE

Sun Pharma - Sun Pharma announces tentative USFDA approvals for generic Januvia and generic Glumetza

15th-Apr-2013 08:38Source: NSE

Sun Pharmaceuticals Industries Limited

10th-Apr-2013 18:36Source: NSE

Sun Pharmaceuticals Industries Limited

3rd-Apr-2013 19:27Source: NSE

Sun Pharmaceuticals Industries Limited

1 2 3 4 5 Next >>
Board Meeting (Sun Pharma)

Meeting Date

Remark

2013-05-28

Others

Add to Watchist
close[x]
Have you invested in these stocks? You can track them better in your Portfolio
Edit Watchlist
JSW Steel Q4 net dips 24% as shortages of iron ore forced it to operate below capacity. Does the mining sector in India require a boost?
Yes
No

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window